Accelerated Approval Reform Proposals Worry Industry: ‘Science Doesn’t Move The Same Way’
During House hearing, PhRMA and BIO highlight provisions of PDUFA VII agreement that the associations say would benefit the pathway more than the additional reforms being considered by Congress.
